Erlotinib plus bevacizumab for EGFR-mutant advanced non-squamous non-small-cell lung cancer patients: ready for first-line?
Adderley, Helen Ackermann, Christoph J Califano, Raffaele
Adderley, Helen
Ackermann, Christoph J
Califano, Raffaele
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Keywords
Type
Article
Citation
Adderley H, Ackermann CJ, Califano R. Erlotinib plus bevacizumab for EGFR-mutant advanced non-squamous non-small-cell lung cancer patients: ready for first-line? Annals of Translational Medicine. 2019;7(S8):S346-S.